These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26728665)

  • 21. Establishment of a predictive model for short-term efficacy of transcatheter arterial chemoembolization treatment in hepatocellular carcinoma and its clinical application.
    Wei J; Wang Z
    J Cancer Res Ther; 2019; 15(4):941-946. PubMed ID: 31436256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
    Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
    Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
    Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
    J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the combination of serum levels of vascular endothelial growth factor, C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization.
    Xuan ZD; Zhou L; Wang Y; Zheng X
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1169-1178. PubMed ID: 29048943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Lin CI; Lin ZY; Hsieh MY; Huang CF; Chen SH; Chuang WL
    Kaohsiung J Med Sci; 2011 Dec; 27(12):554-9. PubMed ID: 22208538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization.
    Tang L; Zhang XM
    Ann Palliat Med; 2020 Jul; 9(4):2111-2117. PubMed ID: 32762227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE.
    Jun CH; Ki HS; Lee KH; Park KJ; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Clin Mol Hepatol; 2013 Mar; 19(1):70-7. PubMed ID: 23593612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of serum HIF-1α/HIF-2α and YKL-40 levels for vascular invasion and prognosis of follicular thyroid cancer.
    Li J; Yu K; Chen D; Luo G; Jia J
    Clinics (Sao Paulo); 2024; 79():100486. PubMed ID: 39277981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
    Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
    Ranieri G; Ammendola M; Marech I; Laterza A; Abbate I; Oakley C; Vacca A; Sacco R; Gadaleta CD
    World J Gastroenterol; 2015 May; 21(19):6018-25. PubMed ID: 26019468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
    Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
    Wu YQ; Fan WZ; Xue M; Guo J; Wei JL; Wang Y; Yao W; Zhao Y; Li JP
    Clin Transl Oncol; 2020 Jan; 22(1):70-80. PubMed ID: 31183764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].
    Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C
    Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Hiraoka A; Ishimaru Y; Kawasaki H; Aibiki T; Okudaira T; Toshimori A; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
    Oncology; 2015; 89(3):167-74. PubMed ID: 25999038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.